Xponance, Inc. Fate Therapeutics Inc Transaction History

Xponance, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$29.67 - $60.28 $113,369 - $230,329	-3,821 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$47.84 - $64.34 $717 - $965	15 Added 0.39%	3,821 $224,000
Q3 2021 Nov 05, 2021	SELL	$59.27 - $95.73 $34,613 - $55,906	-584 Reduced 13.3%	3,806 $226,000
Q2 2021 Aug 12, 2021	BUY	$67.25 - $92.52 $295,227 - $406,162	4,390 New	4,390 $381,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $160M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.